Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $72.6700 (-1.57%) ($70.7100 - $75.0600) on Fri. Mar. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.26% (three month average) | RSI | 38 | Latest Price | $72.6700(-1.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 1.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -9.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(58%) SPLV(46%) VYM(44%) DIA(42%) IVE(42%) | Factors Impacting ABBV price | ABBV will decline at least -1.63% in a week (0% probabilities). VIXM(-27%) UUP(-11%) VXX(-9%) TLT(-8%) TIP(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.63% (StdDev 3.26%) | Hourly BBV | 0.9 () | Intraday Trend | 1.3% | | | |
|
1 - 5 Day Possible Target | $50.93(-29.92%) | Resistance Level | $78.18 | 5 Day Moving Average | $69.28(4.89%) | 10 Day Moving Average | $70.42(3.2%) | 20 Day Moving Average | $78.18(-7.05%) | To recent high | -25.7% | To recent low | 12.7% | Market Cap | $128.21b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |